Company: OCEA
Filing Date: 2025-08-14
Form Type: NT 10-Q
Source: 0001641172-25-023734
Chunk: 1

Company: Ocean Biomedical, Inc.
Filing Date: 2025-08-14
Form: NT 10-Q
Chunk 1
---
 the subject quarterly report     
 or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the     
 fifth calendar day following the prescribed due date; and                                                                             |
|   | -c | The                                                                                                                                   
 accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached                                                  
 if applicable.                                                                                                                        |

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Company is working with its auditor to complete the necessary review and sign off on its Form 10-Q. The Company expects to file its Quarterly Report with the U.S. Securities and Exchange Commission within 5 calendar days of the prescribed due date.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

| Chirinjeev 
 Kathuria   |     |   630 |     | 240-9958          |
| (Name)     |     | -Area 
  Code |     | -Telephone Number |

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s). Yes ☒ No ☐

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof ?

Yes☐ No ☒

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. N/A.

| Ocean                            
 Biomedical, Inc.                 |
| (Name of Registrant as Specified 
 in Charter)                      |

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: | August   
 14, 2025 |     | Ocean Biomedical, Inc. 
 By:                    | /s/                           
 Chirinjee